Hydrocodone Combo Products Reclassified to Schedule II Drugs – Dental Regulations

Effective October 6, 2014, the US Drug Enforcement Agency (DEA) restricted hydrocodone combination products (HCPs), which include Vicodin®, Lortab®, and Hycodan®, from Schedule III to the more restrictive Schedule II. Hydrocodone is a strong pain-killer, with similar complications and risks…

Read More